Doxercalciferol
Doxercalciferol is a prescription medication available as oral capsules in strengths of 0.5 mcg, 1 mcg, and 2.5 mcg. It is a vitamin D2 analog used to help regulate calcium and phosphorus levels in the body, particularly for patients with certain kidney conditions. Manufactured by Heritage Pharmaceuticals and Chartwell RX, LLC, this generic drug is approved under ANDA 205360. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Doxercalciferol is a prescription medication available as oral capsules in strengths of 0.5 mcg, 1 mcg, and 2.5 mcg. It is a vitamin D2 analog used to help regulate calcium and phosphorus levels in the body, particularly for patients with certain kidney conditions. Manufactured by Heritage Pharmaceuticals and Chartwell RX, LLC, this generic drug is approved under ANDA 205360. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Doxercalciferol",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Doxercalciferol — ANDA 210452 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210452"
}
]
|
| identifier | ANDA210452 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"drug-safety",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Doxercalciferol |
